• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Imatinib/Gleevec Treatment of Schistosomiasis

Christoph Grevelding of Justus-Liebig-University in Germany will test the effectiveness of Imatinib, a cancer drug which inhibits kinase activity and cellular changes in cells, to impair and kill parasitic worms which carry Schistosomiasis. If successful, Imatinib could serve as a new drug therapy to fight this chronic disease which affects millions in developing countries.

More information about Create New Ways to Protect Against Infectious Disease (Round 5)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.